Zobrazeno 1 - 10
of 47
pro vyhledávání: '"J. Damato"'
Publikováno v:
IEEE Transactions on Nuclear Science. 41:2304-2309
Using fully-depleted technology, the Loral 256K SOI SRAM has demonstrated under worst case SEU and prompt dose testing an LET threshold of at least 80 MeV cm/sup /spl and/2//mg, and a prompt dose rate upset level of greater then 4E10 rad(Si)/s, respe
Autor:
Sarah A. Fuller, Joseph J. Drabick, Jeffrey L. Lennox, Robert D. Knight, Donald S. Burke, James J. Damato, Philip E. Coyne, Charles N. Oster, Thomas A. Dillard, Virginia L. Horning
Publikováno v:
Military Medicine. 156:93-96
Some individuals possess antibodies which react to HIV-1 Western blot proteins in patterns not diagnostic for HIV infection. A retrospective chart review of patients exhibiting such indeterminate HIV Western blots was performed in comparison to a con
Autor:
Sarah A. Fuller, James J. Damato, Chester R. Roberts, Donald S. Burke, Robert R. Redfield, Barbara N. O’Bryen
Publikováno v:
Laboratory Medicine. 22:107-113
The Department of Defense HIV-1 Test Program was designed to provide timely, accurate, and cost-effective HIV-1 testing services for military personnel. This program incorporated a comprehensive quality assurance and quality improvement program in co
Autor:
James J. Damato, Michael T. Collins
Publikováno v:
Veterinary Microbiology. 22:31-42
The ability of BACTEC radiometric 7H12 broth, Middlebrook 7H10 Tween broth, Middlebrook 7H10 agar, and Herrold's egg-yolk medium to provide early detection of Mycobacterium paratuberculosis was evaluated. The minimum detection times in days for the v
Publikováno v:
Workshop Record 1992 IEEE Radiation Effects Data Workshop.
The IBM 256 K SRAM is a high-performance, low-power device designed and fabricated in 0.8- mu m Enhanced Radiation-Hardened CMOS technology (RHCMOS-E). It is organized in a 32 K*8 or 256 K*1 configuration and is available with either CMOS or TTL inpu
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 5(11)
The laboratory reliability and validity of sex hormone measurements were examined at multiple levels, including lower levels characteristic of children and postmenopausal women. Serum was drawn from four adult male and four adult female healthy volun
Publikováno v:
JAMA. 269(22)
First, to determine whether there is evidence for loss of human immunodeficiency virus type 1 (HIV-1) antibody in seroreactive individuals. Second, if true seroreversion occurs, to determine its incidence relative to errors in the testing process.A r
Autor:
J J, Drabick, V L, Horning, J L, Lennox, P E, Coyne, C N, Oster, R D, Knight, T A, Dillard, S A, Fuller, J J, Damato, D S, Burke
Publikováno v:
Military medicine. 156(2)
Some individuals possess antibodies which react to HIV-1 Western blot proteins in patterns not diagnostic for HIV infection. A retrospective chart review of patients exhibiting such indeterminate HIV Western blots was performed in comparison to a con
Publikováno v:
JAMA: The Journal of the American Medical Association. 270:2179
In Reply. —We concur with Tenenbaum et al that our results do not, and cannot, absolutely rule out the possibility that seroreversion of HIV antibody status may occur. Our conclusion is therefore that if seroreversion occurs, it is exceedingly rare
Publikováno v:
JAMA: The Journal of the American Medical Association. 269:2876
Objectives. —First, to determine whether there is evidence for loss of human immunodeficiency virus type 1 (HIV-1 ) antibody in seroreactive individuals. Second, if true seroreversion occurs, to determine its incidence relative to errors in the tes